The market size of the global anesthesia and respiratory devices will be estimated at USD 57.2 billion in 2025 and is expected to grow to between USD 60.5 billion in 2026 and about USD 100.5 billion by 2035 with a current CAGR of 5.8% during the period of 2026 to 2035.
Anesthesia and Respiratory Devices Market Revenue and Trends
Medical equipment such as anesthesia and respiratory devices is essential in performing surgical procedures, resuscitating patients, and treating acute or chronic respiratory conditions. The anesthesia device's primary components are anesthesia machines, vaporization, gas delivery systems, and airway management. The devices allow for the control of anesthetic agent administration as well as the support of the patient’s vital functions during surgery. Respiratory devices, on the other hand, include ventilators, oxygen concentrators, nebulizers, inhalers, and non-invasive ventilation systems, which either assist or replace the patient’s breathing and also provide extra oxygen to patients with respiratory diseases.
The use of all these technologies together in hospitals, outpatient surgery centers, and home care is indeed imperative as it guarantees patients' safety, proper ventilation, and good perioperative and respiratory care. The anesthesia and respiratory devices market is driven by several factor such as the rising prevalence of respiratory diseases, the increase in surgical procedures globally, the growing geriatric population, technological advancements, and the expansion of home healthcare and ambulatory services.
.png)
What are the Factors That Have a Significant Contribution to the Growth of the Anesthesia and Respiratory Devices Market?
The anesthesia and respiratory devices market is on a continuous upward trajectory and its growth is strongly determined by various interrelated factors such as clinical, demographic, and technological. Among these, the increase in disease prevalence is the foremost reason, which is characterized by the increasing number of patients suffering from respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and acute respiratory infections. This trend is further accompanied by the demand for ventilators, oxygen therapy systems, nebulizers, and non-invasive ventilation devices. Additionally, the increase in surgical operations worldwide has also played a huge part in the adoption of anesthesia machines, airway management devices, and patient monitoring systems.
The world's population is aging, which leads to an increase in the incidence of chronic diseases, trauma cases, and elective surgeries among others. Thus, surgery has moved toward using anesthetics more and more. Meanwhile, the development of very sophisticated technology such as smart anesthesia workstations, advanced ventilation modes, AI-enabled monitoring, and portable devices has made safety, efficiency, and clinical outcomes better thus accelerating adoption. At the same time, home healthcare and the increasing popularity of ambulatory surgical centers are gradually eliminating the need for traditional hospitals, and users of healthcare are getting more and more dependent on compact, cost-effective, and user-friendly devices. The growth of the anesthesia and respiratory devices market is greatly influenced by the factors mentioned such as increased healthcare spending, better access to medical services in developing countries, favorable reimbursement policies in the developed world, and heightened patients’ and medical staff awareness of early diagnosis and respiratory care.
Segment Insight
By End User
The homecare settings segment is growing at a significant rate over the projected period. The development of miniaturization, longer battery life, and digital connectivity has turned these devices into safer, trustworthy and user-friendly products even outside the hospitals for patients and caregivers alike. Moreover, increasing healthcare costs, not enough room in hospitals, and the patients' choice to be treated in their own surroundings are all factors that speed up the movement toward home care.
Regional Insights
The anesthesia and respiratory devices market has been dominated by North America. The fast growth of home healthcare and outpatient care models, especially in the United States and Canada, keeps the application area of anesthesia and respiratory devices wide open, which in turn supports North America's leading position in the global market regarding revenue growth.
Besides, the Asia Pacific market has the highest rate of growth in the anesthesia and respiratory devices market. The device uptake is being hastened by the increasing use of affordable and portable devices, together with the swift development of private hospitals, ambulatory surgical centers, and home healthcare services.
Report Scope
Feature of the Report | Details |
Market Size in 2026 | USD 60.5 billion |
Projected Market Size in 2035 | USD 100.5 billion |
Market Size in 2025 | USD 57.2 billion |
CAGR Growth Rate | 5.8% CAGR |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Key Segment | By Product, End User and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
In October 2025, GaleMed Corporation has initiated the launch of BioVent-Circuit™, a product that can claim the title of the world's first anesthesia breathing circuit, composed of bioplastic derived from sugarcane. This international debut will take place at MEDICA 2025, in Düsseldorf, Germany, and the product is set to be a pioneer in the area of environmental care and clinical safety together. (Source: https://www.galemed.com/en/new/galemed-lanuch-biovent-circuit-medica)
List of the prominent players in the Anesthesia and Respiratory Devices Market:
Medtronic
O2 Concepts
Koninklijke Philips N.V.
Drägerwerk AG & Co. KGaA
Getinge AB.
Smiths Group plc
Fisher & Paykel Healthcare Limited.
Masimo
B. Braun Melsungen AG
ResMed
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
Inogen Inc.
Caire Medical (a subsidiary of NGK Spark Plug),
DeVilbiss Healthcare (a subsidiary of Drive Medical)
React Health (Respiratory Product Line from Invacare Corporation)
Teleflex Incorporated
Nidek Medical Products Inc.
Omron Corporation
GE Healthcare
Others
The Anesthesia and Respiratory Devices Market is segmented as follows:
By Product
Anesthesia Devices
Machines
Workstations
Monitors
Ventilators
Delivery machines
Standalone
Portable
Disposables
Disposable Accessories
Disposable Masks
Respiratory Devices
Disposables
Disposable Oxygen Masks
Resuscitators
Tracheostomy Tubes
Oxygen Cannula
Equipment
Reusable Resuscitators
Ventilators
Adult Ventilators
Neonatal ventilators
Positive Airway Pressure
Bi-level positive airway pressure devices
Continuous positive airway pressure devices
Nebulizers
Pneumatic nebulizers
Mesh nebulizers
Ultrasonic nebulizers
Inhalers
Dry powdered inhalers
Metered-dose inhaler
Humidifiers
Heat exchangers
Pass over humidifiers
Heat humidifiers
Heated wire breathing circuits
Oxygen Concentrators
Portable oxygen concentrators
Fixed oxygen concentrators
Measurement Devices
Spirometers
Pulse Oximeters
Capnography
Peak Flow Meters
By End User
Hospitals
Clinics
Homecare Settings
Ambulatory Service Centers
Regional Coverage:
North America
U.S.
Canada
Mexico
Rest of North America
Europe
Germany
France
U.K.
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Taiwan
Rest of Asia Pacific
The Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
